GlassScriptPhysician profile
Michelle Toole
NPI 1336647536
$2,224.87
in general payments reported to CMS, 2019-2025
35 companies · $345 in 2025
The $345 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.97 · 2022: $518 · 2023: $927 · 2024: $374 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,645.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $253.34 | 2022-2023 | |
| Myriad Women'S Health, INC. | $184.48 | 2023 | Myrisk |
| Daiichi Sankyo INC. | $145.01 | 2022-2024 | Injectafer |
| Abbott Laboratories | $142.18 | 2025 | Freestyle Libre 3 |
| Neurocrine Biosciences, INC. | $134.18 | 2023 | |
| Exeltis, USA INC. | $133.76 | 2022-2025 | Slynd |
| Insmed, INC. | $125.00 | 2022 | |
| Genzyme Corporation | $124.80 | 2024 | |
| Sobi, INC | $86.95 | 2023 | |
| Argenx US, INC. | $85.99 | 2022 | |
| Agile Therapeutics, INC. | $73.11 | 2022-2024 | Twirla |
| Astellas Pharma US INC | $67.14 | 2024-2025 | Veozah |
| Genentech USA, INC. | $61.97 | 2021 | |
| Exact Sciences Corporation | $59.77 | 2023 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $57.45 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $51.81 | 2023-2024 | Myfembree, Gemtesa |
| Novo Nordisk INC | $39.37 | 2023 | Wegovy |
| Medtronic, INC. | $38.88 | 2023 | Ligasure |
| Myovant Sciences INC. | $34.70 | 2022 | |
| Mayne Pharma Commercial LLC | $28.67 | 2025 | |
| Channel Medsystems, INC. | $27.93 | 2024 | |
| Shield Therapeutics INC | $24.48 | 2022 | |
| Coopersurgical, INC. | $24.36 | 2025 | Sos |
| Biohaven Pharmaceutical Holding Company LTD. | $23.74 | 2022 | |
| Edwards Lifesciences Corporation | $22.42 | 2024 | Hemosphere |
| Organon LLC | $21.35 | 2024 | |
| Solventum Corporation | $20.61 | 2025 | Prevena, V.A.C. Dermatac, Activ.A.C. |
| Pfizer INC. | $19.96 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.84 | 2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $17.01 | 2023 | |
| Mylan Pharmaceuticals INC. | $16.78 | 2022 | |
| Hologic Sales and Service, LLC | $16.77 | 2022 | |
| Scynexis, INC. | $14.96 | 2022 | |
| Supernus Pharmaceuticals, INC. | $14.05 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $14.05 | 2025 | Zurzuvae |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Toole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.